Draft Genome Sequence of

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Re-routing MAP kinase signaling for penetration peg formation in predator yeasts.PLoS pathogens · 2024
   Article
2. Use of the Saccharomycopsis schoenii MET17 promoter for regulated heterologous gene expression.Current genetics · 2024
   Article
3. Biocontrol yeasts: mechanisms and applications.World journal of microbiology & biotechnology · 2019
   Review
4. Multi-omics characterization of the necrotrophic mycoparasite Saccharomycopsis schoenii.PLoS pathogens · 2019
   Article
5. The mycoparasitic yeast Saccharomycopsis schoenii predates and kills multi-drug resistant Candida auris.Scientific reports · 2018
   Article
6. Draft Genome Sequence ofGenome announcements · 2018
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.